AAAAAA

   
Results: 1-19 |
Results: 19
NEW TARGETS FOR THERAPEUTIC ATTACK
Authors: WAKELING AE BARKER AJ DAVIES DH BROWN DS GREEN LR CARTLIDGE SA WOODBURN JR
Citation: Ae. Wakeling et al., NEW TARGETS FOR THERAPEUTIC ATTACK, Endocrine-related cancer, 4(3), 1997, pp. 351-355
NEW EGF-R SELECTIVE TYROSINE KINASE INHIBITOR REVEALS VARIABLE GROWTH-RESPONSES IN PROSTATE CARCINOMA CELL-LINES PC-3 AND DU-145
Authors: JONES HE DUTKOWSKI CM BARROW D HARPER ME WAKELING AE NICHOLSON RJ
Citation: He. Jones et al., NEW EGF-R SELECTIVE TYROSINE KINASE INHIBITOR REVEALS VARIABLE GROWTH-RESPONSES IN PROSTATE CARCINOMA CELL-LINES PC-3 AND DU-145, International journal of cancer, 71(6), 1997, pp. 1010-1018
SHORT-TERM EFFECTS OF PURE ANTIESTROGEN ICI-182780 TREATMENT ON ESTROGEN-RECEPTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA PROTEIN EXPRESSION IN HUMAN BREAST-CANCER
Authors: MCCLELLAND RA GEE JMW FRANCIS AB ROBERTSON JFR BLAMEY RW WAKELING AE NICHOLSON RI
Citation: Ra. Mcclelland et al., SHORT-TERM EFFECTS OF PURE ANTIESTROGEN ICI-182780 TREATMENT ON ESTROGEN-RECEPTOR, EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA PROTEIN EXPRESSION IN HUMAN BREAST-CANCER, European journal of cancer, 32A(3), 1996, pp. 413-416
EFFECTS OF SHORT-TERM ANTIESTROGEN TREATMENT OF PRIMARY BREAST-CANCERON ESTROGEN-RECEPTOR MESSENGER-RNA AND PROTEIN EXPRESSION AND ON ESTROGEN-REGULATED GENES
Authors: MCCLELLAND RA MANNING DL GEE JMW ANDERSON E CLARKE R HOWELL A DOWSETT M ROBERTSON JE BLAMEY RW WAKELING AE NICHOLSON RI
Citation: Ra. Mcclelland et al., EFFECTS OF SHORT-TERM ANTIESTROGEN TREATMENT OF PRIMARY BREAST-CANCERON ESTROGEN-RECEPTOR MESSENGER-RNA AND PROTEIN EXPRESSION AND ON ESTROGEN-REGULATED GENES, Breast cancer research and treatment, 41(1), 1996, pp. 31-41
SPECIFIC-INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE BY 4-ANILINOQUINAZOLINES
Authors: WAKELING AE BARKER AJ DAVIES DH BROWN DS GREEN LR CARTLIDGE SA WOODBURN JR
Citation: Ae. Wakeling et al., SPECIFIC-INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE BY 4-ANILINOQUINAZOLINES, Breast cancer research and treatment, 38(1), 1996, pp. 67-73
COMPARISON OF THE EFFECTS OF A PURE STEROIDAL ANTIESTROGEN WITH THOSEOF TAMOXIFEN IN A MODEL OF HUMAN BREAST-CANCER
Authors: OSBORNE CK CORONADOHEINSOHN EB HILSENBECK SG MCCUE BL WAKELING AE MCCLELLAND RA MANNING DL NICHOLSON RI
Citation: Ck. Osborne et al., COMPARISON OF THE EFFECTS OF A PURE STEROIDAL ANTIESTROGEN WITH THOSEOF TAMOXIFEN IN A MODEL OF HUMAN BREAST-CANCER, Journal of the National Cancer Institute, 87(10), 1995, pp. 746-750
OBSERVATIONS ARISING FROM THE USE OF PURE ANTIESTROGENS ON ESTROGEN-RESPONSIVE (MCF-7) AND ESTROGEN GROWTH-INDEPENDENT (K3) HUMAN BREAST-CANCER CELLS
Authors: NICHOLSON RI GEE JMW FRANCIS AB MANNING DL WAKELING AE KATZENELLENBOGEN BS
Citation: Ri. Nicholson et al., OBSERVATIONS ARISING FROM THE USE OF PURE ANTIESTROGENS ON ESTROGEN-RESPONSIVE (MCF-7) AND ESTROGEN GROWTH-INDEPENDENT (K3) HUMAN BREAST-CANCER CELLS, Endocrine-related cancer, 2(1), 1995, pp. 115-121
TISSUE-SPECIFIC ACTIONS OF ANTIESTROGENS
Authors: WAKELING AE
Citation: Ae. Wakeling, TISSUE-SPECIFIC ACTIONS OF ANTIESTROGENS, Mutation research, 333(1-2), 1995, pp. 45-49
MCF-7 HUMAN MAMMARY ADENOCARCINOMA CELL-DEATH IN-VITRO IN RESPONSE TOHORMONE-WITHDRAWAL AND DNA-DAMAGE
Authors: WILSON JW WAKELING AE MORRIS ID HICKMAN JA DIVE C
Citation: Jw. Wilson et al., MCF-7 HUMAN MAMMARY ADENOCARCINOMA CELL-DEATH IN-VITRO IN RESPONSE TOHORMONE-WITHDRAWAL AND DNA-DAMAGE, International journal of cancer, 61(4), 1995, pp. 502-508
USE OF PURE ANTIESTROGENS TO ELUCIDATE THE MODE OF ACTION OF ESTROGENS
Authors: WAKELING AE
Citation: Ae. Wakeling, USE OF PURE ANTIESTROGENS TO ELUCIDATE THE MODE OF ACTION OF ESTROGENS, Biochemical pharmacology, 49(11), 1995, pp. 1545-1549
THE IMPORTANCE OF TAMOXIFEN METABOLISM IN TAMOXIFEN-STIMULATED BREAST-TUMOR GROWTH
Authors: OSBORNE CK JARMAN M MCCAGUE R CORONADO EB HILSENBECK SG WAKELING AE
Citation: Ck. Osborne et al., THE IMPORTANCE OF TAMOXIFEN METABOLISM IN TAMOXIFEN-STIMULATED BREAST-TUMOR GROWTH, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 89-95
EFFECTS OF A NONSTEROIDAL PURE ANTIESTROGEN, ZM-189,154, ON ESTROGEN TARGET ORGANS OF THE RAT INCLUDING BONES
Authors: DUKES M CHESTER R YARWOOD L WAKELING AE
Citation: M. Dukes et al., EFFECTS OF A NONSTEROIDAL PURE ANTIESTROGEN, ZM-189,154, ON ESTROGEN TARGET ORGANS OF THE RAT INCLUDING BONES, Journal of Endocrinology, 141(2), 1994, pp. 335-341
INVESTIGATION OF A NEW PURE ANTIESTROGEN (ICI-182780) IN WOMEN WITH PRIMARY BREAST-CANCER
Authors: DEFRIEND DJ HOWELL A NICHOLSON RI ANDERSON E DOWSETT M MANSEL RE BLAMEY RW BUNDRED NJ ROBERTSON JF SAUNDERS C BAUM M WALTON P SUTCLIFFE F WAKELING AE
Citation: Dj. Defriend et al., INVESTIGATION OF A NEW PURE ANTIESTROGEN (ICI-182780) IN WOMEN WITH PRIMARY BREAST-CANCER, Cancer research, 54(2), 1994, pp. 408-414
ARE BREAST-TUMORS RESISTANT TO TAMOXIFEN ALSO RESISTANT TO PURE ANTIESTROGENS
Authors: WAKELING AE
Citation: Ae. Wakeling, ARE BREAST-TUMORS RESISTANT TO TAMOXIFEN ALSO RESISTANT TO PURE ANTIESTROGENS, Journal of steroid biochemistry and molecular biology, 47(1-6), 1993, pp. 107-114
TYPE-I IGF RECEPTOR AND ACQUIRED TAMOXIFEN RESISTANCE IN ESTROGEN-RESPONSIVE HUMAN BREAST-CANCER CELLS
Authors: WISEMAN LR JOHNSON MD WAKELING AE LYKKESFELDT AE MAY FEB WESTLEY BR
Citation: Lr. Wiseman et al., TYPE-I IGF RECEPTOR AND ACQUIRED TAMOXIFEN RESISTANCE IN ESTROGEN-RESPONSIVE HUMAN BREAST-CANCER CELLS, European journal of cancer, 29A(16), 1993, pp. 2256-2264
APOPTOTIC DEATH IN EPITHELIAL-CELLS - CLEAVAGE OF DNA TO 300 AND OR 50 KB FRAGMENTS PRIOR TO OR IN THE ABSENCE OF INTERNUCLEOSOMAL FRAGMENTATION
Authors: OBERHAMMER F WILSON JW DIVE C MORRIS ID HICKMAN JA WAKELING AE WALKER PR SIKORSKA M
Citation: F. Oberhammer et al., APOPTOTIC DEATH IN EPITHELIAL-CELLS - CLEAVAGE OF DNA TO 300 AND OR 50 KB FRAGMENTS PRIOR TO OR IN THE ABSENCE OF INTERNUCLEOSOMAL FRAGMENTATION, EMBO journal, 12(9), 1993, pp. 3679-3684
THE FUTURE OF NEW PURE ANTIESTROGENS IN CLINICAL BREAST-CANCER
Authors: WAKELING AE
Citation: Ae. Wakeling, THE FUTURE OF NEW PURE ANTIESTROGENS IN CLINICAL BREAST-CANCER, Breast cancer research and treatment, 25(1), 1993, pp. 1-9
ANTIUTEROTROPHIC EFFECTS OF THE PURE ANTIESTROGEN ICI 182,780 IN ADULT FEMALE MONKEYS (MACACA-NEMESTRINA) - QUANTITATIVE MAGNETIC-RESONANCE-IMAGING
Authors: DUKES M WATERTON JC WAKELING AE
Citation: M. Dukes et al., ANTIUTEROTROPHIC EFFECTS OF THE PURE ANTIESTROGEN ICI 182,780 IN ADULT FEMALE MONKEYS (MACACA-NEMESTRINA) - QUANTITATIVE MAGNETIC-RESONANCE-IMAGING, Journal of Endocrinology, 138(2), 1993, pp. 203
MCF7 LCC2 - A 4-HYDROXYTAMOXIFEN RESISTANT HUMAN BREAST-CANCER VARIANT THAT RETAINS SENSITIVITY TO THE STEROIDAL ANTIESTROGEN ICI-182,780/
Authors: BRUNNER N FRANDSEN TL HOLSTHANSEN C BEI M THOMPSON EW WAKELING AE LIPPMAN ME CLARKE R
Citation: N. Brunner et al., MCF7 LCC2 - A 4-HYDROXYTAMOXIFEN RESISTANT HUMAN BREAST-CANCER VARIANT THAT RETAINS SENSITIVITY TO THE STEROIDAL ANTIESTROGEN ICI-182,780/, Cancer research, 53(14), 1993, pp. 3229-3232
Risultati: 1-19 |